IMPROVED IRON CHELATION WITH DEFERASIROX AND ZINC COMBINATIONAL THREAPY IN PATIENTS WITH BETA THALASSEMIA MAJOR: IS IT ADDITIVE OR SYNERGISTIC?

被引：0
|
作者：
Unal, S. [1 ]
Celik, T. [2 ]
Ozer, C. [2 ]
Ilhan, G. [1 ]
Oktay, G. [1 ]
机构：
[1] Antakya State Hosp, Antakya, Turkey
[2] Mustafa Kemal Univ, Antakya, Turkey
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0930
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [1] Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox
    Economou, Marina
    Printza, Nikoletta
    Teli, Aikaterini
    Tzimouli, Vassiliki
    Tsatra, Ioanna
    Papachristou, Fotis
    Athanassiou-Metaxa, Miranda
    ACTA HAEMATOLOGICA, 2010, 123 (03) : 148 - 152
  • [2] Iron Chelation with Deferasirox in Thalassemia Major Patients with Low Iron Burdens and Moderate to High Transfusion Regimens.
    Evans, Elizabeth
    Kleinert, Dorothy A.
    Mennitt, Kevin
    Grady, Robert W.
    Giardina, Patricia J.
    BLOOD, 2009, 114 (22) : 1562 - 1562
  • [3] Long-Term Outcome of Deferasirox Chelation in Patients with Thalassemia Major
    Unal, Sule
    Kalkan, Neslihan
    Cetin, Mualla
    Gumruk, Fatma
    BLOOD, 2016, 128 (22)
  • [4] Iron Chelation in Patients with Transfusion Dependent Thalassemia: An Insight on Response to Deferasirox
    Shaikh, Muhammad Shariq
    Adil, Salman Naseem
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2015, 25 (07): : 553 - 554
  • [5] The Zinc and Copper Levels in Thalassemia Major Patients, Receiving Iron Chelation Therapy
    Zekavat, Omid R.
    Bahmanjahromi, Ayda
    Haghpanah, Sezaneh
    Ebrahimi, Sara
    Cohan, Nader
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (03) : 178 - 181
  • [6] Strategies to Improve Iron Chelation In Thalassemia Patients Poorly Responsive to Deferasirox
    Chirnomas, Deborah
    Yakhkind, Aleksandra
    Paley, Carole S.
    Neufeld, Ellis J.
    BLOOD, 2010, 116 (21) : 1737 - 1737
  • [7] Long Term Efficacy Of Iron Chelation Therapy With Deferasirox On Endocrine Function In Thalassemia Major
    Casale, Maddalena
    Citarella, Serena
    Filosa, Aldo
    De Michele, Elisa
    Pugliese, Umberto
    Francesco, Palmieri
    Ragozzino, Alfonso
    Giovanni, Amendola
    Tartaglione, Immacolata
    Della Rocca, Milena
    Nobili, Bruno
    Silverio, Perrotta
    BLOOD, 2013, 122 (21)
  • [8] Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
    Alavi, Samin
    Sadeghi, Elham
    Ashenagar, Azin
    BLOOD RESEARCH, 2014, 49 (01) : 72 - 73
  • [9] EVALUATION OF IRON CHELATION THERAPY IN BETA THALASSEMIA MAJOR PATIENTS IN EAST DELTA OF EGYPT
    Badr, M.
    Hesham, M.
    Hassan, T.
    Badawy, S. M.
    PEDIATRIC RESEARCH, 2010, 68 : 423 - 424
  • [10] Effective Iron Chelation Practice for Patients With β-Thalassemia Major
    Carson, Susan M.
    Martin, Marie B.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2014, 18 (01) : 102 - 111
12345